100 related articles for article (PubMed ID: 10682709)
1. Early direct and transneuronal effects in mice with targeted expression of a toxin gene to D1 dopamine receptor neurons.
Padungchaichot P; Wong JY; Natoli AL; Massalas JS; Finkelstein DI; Lawrence AL; Drago J
Neuroscience; 2000; 95(4):1025-33. PubMed ID: 10682709
[TBL] [Abstract][Full Text] [Related]
2. Late direct and transneuronal effects in mice with targeted expression of a toxin gene to D1 dopamine receptor neurons.
Wong JY; Padungchaichot P; Massalas JS; Drago J
Neuroscience; 2000; 95(4):1035-41. PubMed ID: 10682710
[TBL] [Abstract][Full Text] [Related]
3. Long-term striatal overexpression of GDNF selectively downregulates tyrosine hydroxylase in the intact nigrostriatal dopamine system.
Rosenblad C; Georgievska B; Kirik D
Eur J Neurosci; 2003 Jan; 17(2):260-70. PubMed ID: 12542662
[TBL] [Abstract][Full Text] [Related]
4. Dopamine control of striatal gene expression during development: relevance to knockout mice for the dopamine transporter.
Fauchey V; Jaber M; Bloch B; Le Moine C
Eur J Neurosci; 2000 Sep; 12(9):3415-25. PubMed ID: 10998124
[TBL] [Abstract][Full Text] [Related]
5. Development of striatal dopaminergic function. I. Pre- and postnatal development of mRNAs and binding sites for striatal D1 (D1a) and D2 (D2a) receptors.
Jung AB; Bennett JP
Brain Res Dev Brain Res; 1996 Jul; 94(2):109-20. PubMed ID: 8836569
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial toxins in models of neurodegenerative diseases. II: Elevated zif268 transcription and independent temporal regulation of striatal D1 and D2 receptor mRNAs and D1 and D2 receptor-binding sites in C57BL/6 mice during MPTP treatment.
Smith TS; Trimmer PA; Khan SM; Tinklepaugh DL; Bennett JP
Brain Res; 1997 Aug; 765(2):189-97. PubMed ID: 9313891
[TBL] [Abstract][Full Text] [Related]
7. Targeted expression of a toxin gene to D1 dopamine receptor neurons by cre-mediated site-specific recombination.
Drago J; Padungchaichot P; Wong JY; Lawrence AJ; McManus JF; Sumarsono SH; Natoli AL; Lakso M; Wreford N; Westphal H; Kola I; Finkelstein DI
J Neurosci; 1998 Dec; 18(23):9845-57. PubMed ID: 9822743
[TBL] [Abstract][Full Text] [Related]
8. Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum.
Aubert I; Ghorayeb I; Normand E; Bloch B
J Comp Neurol; 2000 Feb; 418(1):22-32. PubMed ID: 10701753
[TBL] [Abstract][Full Text] [Related]
9. Rats bred for enhanced apomorphine susceptibility have elevated tyrosine hydroxylase mRNA and dopamine D2-receptor binding sites in nigrostriatal and tuberoinfundibular dopamine systems.
Rots NY; Cools AR; Bérod A; Voorn P; Rostène W; de Kloet ER
Brain Res; 1996 Feb; 710(1-2):189-96. PubMed ID: 8963658
[TBL] [Abstract][Full Text] [Related]
10. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
[TBL] [Abstract][Full Text] [Related]
11. Neurochemical changes in dopamine D1, D3 and D1/D3 receptor knockout mice.
Wong JY; Clifford JJ; Massalas JS; Finkelstein DI; Horne MK; Waddington JL; Drago J
Eur J Pharmacol; 2003 Jul; 472(1-2):39-47. PubMed ID: 12860471
[TBL] [Abstract][Full Text] [Related]
12. Ontogeny of D1A and D2 dopamine receptor subtypes in rat brain using in situ hybridization and receptor binding.
Schambra UB; Duncan GE; Breese GR; Fornaretto MG; Caron MG; Fremeau RT
Neuroscience; 1994 Sep; 62(1):65-85. PubMed ID: 7816213
[TBL] [Abstract][Full Text] [Related]
13. On the distribution patterns of D1, D2, tyrosine hydroxylase and dopamine transporter immunoreactivities in the ventral striatum of the rat.
Jansson A; Goldstein M; Tinner B; Zoli M; Meador-Woodruff JH; Lew JY; Levey AI; Watson S; Agnati LF; Fuxe K
Neuroscience; 1999 Mar; 89(2):473-89. PubMed ID: 10077329
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical and neurochemical studies on nigral and striatal functions in the circling (ci) rat, a genetic animal model with spontaneous rotational behavior.
Richter A; Ebert U; Nobrega JN; Vallbacka JJ; Fedrowitz M; Löscher W
Neuroscience; 1999 Mar; 89(2):461-71. PubMed ID: 10077328
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic activity in transgenic mice underexpressing glucocorticoid receptors: effect of antidepressants.
Cyr M; Morissette M; Barden N; Beaulieu S; Rochford J; Di Paolo T
Neuroscience; 2001; 102(1):151-8. PubMed ID: 11226678
[TBL] [Abstract][Full Text] [Related]
16. Resolving pathobiological mechanisms relating to Huntington disease: gait, balance, and involuntary movements in mice with targeted ablation of striatal D1 dopamine receptor cells.
Kim HA; Jiang L; Madsen H; Parish CL; Massalas J; Smardencas A; O'Leary C; Gantois I; O'Tuathaigh C; Waddington JL; Ehrlich ME; Lawrence AJ; Drago J
Neurobiol Dis; 2014 Feb; 62():323-37. PubMed ID: 24135007
[TBL] [Abstract][Full Text] [Related]
17. D1 dopamine receptor agonist-induced Fos-like immunoreactivity occurs in basal forebrain and mesopontine tegmentum cholinergic neurons and striatal neurons immunoreactive for neuropeptide Y.
Robertson GS; Staines WA
Neuroscience; 1994 Mar; 59(2):375-87. PubMed ID: 7911982
[TBL] [Abstract][Full Text] [Related]
18. Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism.
St-Hilaire M; Landry E; Lévesque D; Rouillard C
Neurobiol Dis; 2005 Nov; 20(2):450-60. PubMed ID: 15896973
[TBL] [Abstract][Full Text] [Related]
19. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection.
Lapchak PA; Beck KD; Araujo DM; Irwin I; Langston JW; Hefti F
Neuroscience; 1993 Apr; 53(3):639-50. PubMed ID: 8098137
[TBL] [Abstract][Full Text] [Related]
20. Acute and chronic amphetamine treatments differently regulate neuropeptide messenger RNA levels and Fos immunoreactivity in rat striatal neurons.
Jaber M; Cador M; Dumartin B; Normand E; Stinus L; Bloch B
Neuroscience; 1995 Apr; 65(4):1041-50. PubMed ID: 7617160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
